Publications
1. Pape JW, Liautaud B, Thomas F, Mathurin JR, St. Amand M-M, Boncy M, Pean Pamphile M, Laroche AC, Johnson Jr WD. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. New Engl J Med 1983;309:945-50.
2. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson Jr WD. Absent gamma interferon and IL-2 production during active visceral leishmaniasis. J Clin Invest 1985;76:2066-9.
3. DeHovitz JA, Pape JW, Boncy M, Johnson Jr WD. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. New Engl J Med 1986;315:87-90.
4. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson Jr WD. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986;154:1003-11.
5. Badaro R, Falcoff E, Badaro RS, Carvalho EM, Pedral-Sampaio, Barral A, Carvalho JS, Barral-Netto M, Brandely M, Silva L, Bina JC, Teixeira R, Falcoff R, Rocha H, Ho JL, Johnson Jr WD. Treatment of visceral leishmaniasis with pentavalent antimony and interferon-gamma. New Engl J Med 1990;332:16-21.
6. Reed SG, Carvalho EM, Sherbert CH, Pedral-Sampaio D, Russo DM, Bacellar O, Pihl L, Scott JM, Barral A, Grabstein KH, Johnson Jr WD. In-vitro response to leishmania antigens by lymphocytes from patients with leishmaniasis and ChagasÂ’ disease. J Clin Invest 1990;5:690-6.
7. Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, Carvalho LCP, Rocha H, Reed S, Johnson Jr WD. Serum-mediated suppression in human visceral leishmaniasis: role of IgG and soluble interleukin-2 receptor. J Immunol 1991;144:281-4.
8. Pape JW, Jean S, Ho JL, Hafner A, Johnson Jr WD. Isoniazid reduces the development of active tuberculosis and delays the progression of human immunodeficiency virus. Lancet 1993;342:268-72.
9. Pape JW, Verdier R-I, Boncy M, Boncy J, Johnson Jr WD. Cyclospora infection in adults infected with HIV: clinical manifestations, treatment, and prophylaxis. Ann Int Med 1994;121:654-7.
10. Soave R, Johnson Jr WD. Cyclospora: Conquest of an emerging pathogen. Lancet 1995;345:667-8.
11. Deschamps M-M, Pape JW, Hafner A, Johnson Jr WD. Heterosexual transmission of human immunodeficiency virus in Haiti: incidence, co-factors, and prevention. Ann Int Med 1996;125:324-30.
12. Ko AI, Reis MG, Dourado CMR, Johnson WD Jr, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Lancet 1999;354:820-5.
13. Verdier R-I, Fitzgerald DW, Johnson WD Jr, Pape JW. Treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis in HIV-infected patients: trimethroprim-sulfamethoxazole versus ciprofloxacin. Ann Int Med 2000;132:885-8.
14. Deschamps M-M, Fitzgerald DW, Pape JW, Johnson WD Jr. HIV infection in Haiti: natural history and disease progression. AIDS 2000;14:2515-21.
15. Turetz ML, Machado PR, Ko AI, Alvfes F, Bittencourt A, Almeida R, Mobashery N, Johnson WD Jr, Carvalho EM. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 2002;186:1829-34.
16. Fitzgerald DW, Marotte C, Verdier RI, Johnson WD Jr, Pape JW. Comprehension during informed consent in a less-developed country. Lancet 2002;360:1301-2.
17. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright P, Gulick R, Johnson WD Jr, Pape JW, Fitzgerald DW. Antiretroviral therapy for acquired immunodeficiency syndrome in Haiti: experience with one thousand patients. NEJM 2005;343:2325-34.
18. Joseph P, Severe P, Ferdinand S, Goh KS, Sola C, Haas D, Johnson WD, Rastogi N, Pape JW, Fitzgerald DW. Multi-drug resistant tuberculosis at an HIV testing center in Haiti. AIDS 2006;14:20:415-8.
